SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-23-000104
Filing Date
2023-11-07
Accepted
2023-11-07 16:42:39
Documents
14
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20231107.htm   iXBRL 8-K 25999
2 EX-99.1 lumo-2023930x8kxex991.htm EX-99.1 117307
6 lumosa.jpg GRAPHIC 2692
  Complete submission text file 0001126234-23-000104.txt   287382

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lumo-20231107.xsd EX-101.SCH 1998
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lumo-20231107_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lumo-20231107_pre.xml EX-101.PRE 12601
8 EXTRACTED XBRL INSTANCE DOCUMENT lumo-20231107_htm.xml XML 2692
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 231384668
SIC: 2834 Pharmaceutical Preparations